BioAtla, Inc..
BCAB.US | Research and experimental development on natural sciences and engineering
BioAtla, Inc. is a global biotechnology company focused on the discovery and development of conditionally active biologics (CABs). These CABs are designed to be active in the tumor microenvironment, aiming to provide more effective and safer therapies for cancer patients. The company's CAB platform ...Show More
Better Health for All
0
No evidence available to assess BioAtla, Inc. on Better Health for All.
Fair Money & Economic Opportunity
0
No evidence available to assess BioAtla, Inc. on Fair Money & Economic Opportunity.
Fair Pay & Worker Respect
0
No evidence available to assess BioAtla, Inc. on Fair Pay & Worker Respect.
Fair Trade & Ethical Sourcing
0
No evidence available to assess BioAtla, Inc. on Fair Trade & Ethical Sourcing.
Honest & Fair Business
0
No specific, concrete evidence was found in the provided articles to assess BioAtla, Inc. against any of the KPIs for the 'Honest & Fair Business' ethical value. The articles either provided general corporate governance overviews without quantitative data
1
or detailed individual director stock grants,
2
neither of which contained information on regulatory fines, transparency benchmarks, whistle-blower policies, financial restatements, audit coverage, ESG controversies, complaint resolution times, board conflicts of interest, anti-corruption policies, or third-party verification of ethical claims.
3
Kind to Animals
-40
BioAtla, Inc. uses animal modeling data in its research, as evidenced by statements made at The Citizens JMP Life Sciences Conference 2025.
1
However, the company has not explicitly stated its animal testing policy in the provided articles, nor has it provided details on any commitments to reduction or alternative methods.
2
The absence of a stated policy, despite evidence of animal use, indicates a lack of transparency and commitment to animal welfare in this area.
No War, No Weapons
0
BioAtla, Inc. is a clinical-stage biopharmaceutical company focused on developing cancer therapies.
1
The provided articles explicitly state that no quantitative or specific data is directly relevant to the 'No War, No Weapons' initiative, peacebuilding, or conflict divestment activities.
2
The company's core business, as described, does not involve arms manufacturing, military contracts, dual-use technologies, or any other activities related to defense or conflict.
3
Therefore, all relevant KPIs are scored as N/A (0) because there is no evidence of involvement in such activities.
Planet-Friendly Business
-20
In 2023, BioAtla's carbon emissions were 1,245 metric tons of CO2 equivalent.
1
The company sourced 42% of its operational energy from renewables in 2023.
2
No environmental compliance violations were mentioned in the provided articles.
3
Respect for Cultures & Communities
0
No evidence available to assess BioAtla, Inc. on Respect for Cultures & Communities.
Safe & Smart Tech
0
The company has not experienced any material cybersecurity incidents in the last three fiscal years and has implemented several processes, technologies, and controls to manage risks and test its incident response plan, including engaging an assessor to review its program.
1
It provides regular cybersecurity training for employees and management, annual cybersecurity management training for those handling sensitive data, and conducts regular phishing email simulations for all employees and contractors.
2
The company performs regular network and endpoint monitoring, vulnerability assessments, and penetration testing.
3
It closely monitors emerging data protection laws and implements changes to its processes to comply.
4
The company is subject to and mentions compliance with various privacy regulations, including GDPR, HIPAA, CCPA, CPRA, Virginia's Consumer Data Protection Act, Colorado Privacy Act, Connecticut Data Privacy Act, and Utah Consumer Privacy Act.
5
Zero Waste & Sustainable Products
0
No evidence available to assess BioAtla, Inc. on Zero Waste & Sustainable Products.